Physician profile
Ariana Levin
NPI 1538666151
$25,245.45
in general payments reported to CMS, 2019-2025
16 companies · $10K in 2025
The $10K reported for 2025 was more than what 92% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.50 · 2020: $20.51 · 2021: $299 · 2022: $1,214 · 2023: $2,201 · 2024: $11K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $3,156 · Travel and Lodging: $1,617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,917.10 |
| Food and Beverage | $3,156.28 |
| Travel and Lodging | $1,617.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $18,863.37 | 2024-2025 | |
| Alcon Vision LLC | $3,916.43 | 2019-2025 | Hydrus Microstent, Rocklatan, Clareon |
| Sight Sciences, INC. | $680.79 | 2021-2023 | Omni Surgical System, Sion Surgical Instrument |
| Glaukos Corporation | $470.09 | 2021-2025 | Idosetr, Istent Infinite, Idose |
| Abbvie INC. | $423.02 | 2023-2025 | |
| Allergan, INC. | $171.58 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $148.05 | 2022-2024 | Envista Aspire Iol |
| New World Medical,INC. | $137.15 | 2022 | |
| Ocular Therapeutix, INC. | $124.72 | 2021-2024 | Dextenza |
| Aerie Pharmaceuticals, INC. | $101.77 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $84.42 | 2024-2025 | Xdemvy |
| Integra Lifesciences Corporation | $29.96 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Carl Zeiss Meditec USA, INC. | $27.26 | 2021 | |
| Genentech USA, INC. | $26.48 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $25.75 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $14.61 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariana Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.